April 2017: Headlines and Deadlines

"But what about the January 3, 2018, Mifid II deadline? To what extent are capital markets firms’ minds concentrated on that deadline?"

victor-anderson

Deadlines are strange things and people, it seems, are similarly strange when relating to them. British poet and essayist Samuel Johnson once famously commented that, “When a man knows he is to be hanged  … it concentrates his mind wonderfully.” Johnson, fortuitously, wasn’t referring to himself, but rather to the Anglican clergyman, William Dodd, who was hanged on June 27, 1777, for forgery. 

An execution is certainly a deadline that cannot be ignored—it is, after all, literally a matter of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Waterstechnology? View our subscription options

Register for free

Access two articles, our IMD and Waters Wraps, plus a member newsletter. Find out more.

All fields are mandatory unless otherwise highlighted.

Europe is counting its vendors—and souring on US tech

Under DORA, every financial company with business in the EU must report use of their critical vendors. Deadlines vary, but the message doesn’t: The EU is taking stock of technology dependencies, especially upon US providers.

The European T+1 effect on Asia

T+1 is coming in Europe, and Asian firms should assess impacts and begin preparations now, says the DTCC’s Val Wotton.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here